» Articles » PMID: 31323777

Drug Delivery Systems for Vitamin D Supplementation and Therapy

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2019 Jul 21
PMID 31323777
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D (VD) is a fat-soluble prohormone well known for its role in regulating calcium and phosphate metabolism. It has been clinically used for many years to prevent rickets in children, osteomalacia, and osteoporosis in adults. VD insufficiency is a common medical condition, and many supplements are available in the market in order to increase serum 25-hydroxy VD levels to recommended amounts. Over the course of the last decades, it has become increasingly clear that calcitriol, an active form of VD, regulates multiple cellular processes with effects on normal and malignant cell growth and differentiation, and on the immune and cardiovascular function. Increasing evidence supports the role of the VD system in cancer prevention and therapy. Due to many pleiotropic and beneficial effects in extra-skeletal disorders, VD has gained potential and become an interesting active for encapsulation into drug delivery systems. The purpose of this review is to present the diversity of drug delivery systems that have been reported for VD or VD derivatives in an orderly manner across the following categories: Oral administration, application on the skin, cancer prevention/therapy, and other diseases or routes of administration.

Citing Articles

Enzyme-responsive vitamin D-based micelles for paclitaxel-controlled delivery and synergistic pancreatic cancer therapy.

Peixoto D, Ravasco J, Blanco-Fernandez B, Veiga F, Concheiro A, Conde J Mater Today Bio. 2025; 31:101555.

PMID: 40026626 PMC: 11869029. DOI: 10.1016/j.mtbio.2025.101555.


Novel Lipid-Based Carriers of Provitamin D: Synthesis and Spectroscopic Characterization of Acylglycerol Conjugated with 7-Dehydrocholesterol Residue and Its Glycerophospholipid Analogue.

Gladkowski W, Ortlieb S, Niezgoda N, Chojnacka A, Fortuna P, Wiercik P Molecules. 2024; 29(23).

PMID: 39683962 PMC: 11643614. DOI: 10.3390/molecules29235805.


Recent Applications of Amphiphilic Copolymers in Drug Release Systems for Skin Treatment.

Cardona Y, Munoz L, Cardozo D, Chamorro A Pharmaceutics. 2024; 16(9).

PMID: 39339239 PMC: 11435020. DOI: 10.3390/pharmaceutics16091203.


Recent Advances in the Use of Vitamin D Organic Nanocarriers for Drug Delivery.

Aggeletopoulou I, Kalafateli M, Geramoutsos G, Triantos C Biomolecules. 2024; 14(9).

PMID: 39334856 PMC: 11430352. DOI: 10.3390/biom14091090.


A Comparison and Safety Evaluation of Micellar versus Standard Vitamin D Oral Supplementation in a Randomized, Double-Blind Human Pilot Study.

Solnier J, Chang C, Zhang Y, Kuo Y, Du M, Roh Y Nutrients. 2024; 16(11).

PMID: 38892507 PMC: 11174535. DOI: 10.3390/nu16111573.


References
1.
Hansen C, Hamberg K, Binderup E, Binderup L . Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation. Curr Pharm Des. 2000; 6(7):803-28. DOI: 10.2174/1381612003400371. View

2.
Korbel J, Sebok B, Kerenyi M, Mahrle G . Enhancement of the antiparakeratotic potency of calcitriol and tacalcitol in liposomal preparations in the mouse tail test. Skin Pharmacol Appl Skin Physiol. 2001; 14(5):291-5. DOI: 10.1159/000056359. View

3.
Cavalier E, Delanaye P, Chapelle J, Souberbielle J . Vitamin D: current status and perspectives. Clin Chem Lab Med. 2008; 47(2):120-7. DOI: 10.1515/CCLM.2009.036. View

4.
Yamagishi N, Namioka T, Okura N, Sato S, Kim D, Furuhama K . Application of a reservoir-type calcitriol transdermal patch in dairy cattle. J Vet Med Sci. 2009; 71(6):845-8. DOI: 10.1292/jvms.71.845. View

5.
Grossmann R, Tangpricha V . Evaluation of vehicle substances on vitamin D bioavailability: a systematic review. Mol Nutr Food Res. 2010; 54(8):1055-61. PMC: 3033429. DOI: 10.1002/mnfr.200900578. View